Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Endometrial Neoplasms × olaparib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 4 Breast Neoplasms 2 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Metastatic Castration-resistant Prostate Cancer 1 Fanconi Anemia, Complementation Group D1 1 Endometrial Neoplasms 1

Interventions

pembrolizumab 3 Paclitaxel 3 Carboplatin 2 sacituzumab govitecan 1 olaparib 1 lenvatinib 1 durvalumab 1 Taxes 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04269200 2025-12-23

DUO-E

AstraZeneca

Phase 3 Active not recruiting

805 enrolled 18 charts 1 FDA

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡